Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Organigram Global Inc. - Common Shares
(NQ:
OGI
)
1.070
+0.030 (+2.88%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Organigram Global Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada’s Economic Future
April 16, 2025
From
Organigram Holdings Inc.
Via
Business Wire
Cannabis Stock Gainers And Losers From April 11, 2025
April 11, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 9, 2025
April 09, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
OrganiGram Holdings Earnings Review: Q4 Summary
December 18, 2024
Via
Benzinga
OrganiGram Holdings Q4 Earnings Assessment
December 18, 2024
Via
Benzinga
Marijuana Stock Movers For April 7, 2025
April 07, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For April 4, 2025
April 04, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
April 04, 2025
This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.
Via
Benzinga
Topics
Government
Exposures
Political
Cannabis Stock Movers For April 3, 2025
April 03, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ
April 02, 2025
From
Organigram Global Inc.
Via
Business Wire
Organigram Enters U.S. Through Acquisition of Collective Project Beverages
April 01, 2025
From
Organigram Holdings Inc.
Via
Business Wire
This Week In Cannabis: Gaetz's Stock Rally, Major Policy Battles, Homeland Security's Stance, Big Earnings And More
March 28, 2025
Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence
March 26, 2025
From
Organigram Holdings Inc.
Via
Business Wire
Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.
March 24, 2025
From
Organigram Holdings Inc.
Via
Business Wire
Big Tobacco's Latest $86.8 Million Cannabis Investment Signals Growing Industry Influence
March 05, 2025
British American Tobacco finalizes a C$124.6M investment in Organigram, reinforcing big tobacco's stake in cannabis.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment
March 03, 2025
From
Organigram Holdings Inc.
Via
Business Wire
Cannabis Stock Movers For February 17, 2025
February 17, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Organigram (OGI) Q1 2025 Earnings Call Transcript
February 11, 2025
OGI earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Cannabis Producer Organigram Q1 Sales Jump 17%, Expect C$10 Million From Motif Integration, Annual Run-Rate Synergies Within Two Years
February 11, 2025
Organigram's Q1 FY25 sales hit C$66.8M. Net revenue rose 17%, and adjusted EBITDA improved to C$1.4M. Cash position set to reach C$113M.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Organigram Reports First Quarter Fiscal 2025 Results
February 11, 2025
From
Organigram Holdings Inc.
Via
Business Wire
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025
February 04, 2025
From
Organigram Holdings Inc.
Via
Business Wire
Earnings Scheduled For February 11, 2025
February 11, 2025
Via
Benzinga
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
January 08, 2025
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainers
January 01, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Organigram Reports Fourth Quarter and Fiscal 2024 Results
December 20, 2024
From
Organigram Holdings Inc.
Via
Business Wire
Organigram (OGI) Q4 2024 Earnings Call Transcript
December 18, 2024
OGI earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars
December 18, 2024
Organigram's Q4 sales hit $31.22 million, boosted by recreational and international growth, with adjusted gross margin improving to 37% of net revenue.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Earnings Scheduled For December 18, 2024
December 18, 2024
Via
Benzinga
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
December 11, 2024
From
Organigram Holdings Inc.
Via
Business Wire
Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition Deal
December 06, 2024
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has announced the acquisition of 100% of Motif Labs Ltd. for CA$90 million ($64 million), comprising of CA$50 million in cash and CA$40 million in...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.